Clinical Study of Liposomal Mitoxantrone Hydrochloride Injection Combined With Pegaspargase in the Treatment of NKTCL
Clinical trial NCT04509466 · TERMINATED
Trial details
- NCT number
- NCT04509466
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-15
- Primary completion
- 2022-01-30
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.